Payment overview · 2025
General Payments
$133.06
5 reported records · 2 companies
Healthcare provider profile · identity verified
Keyur Patel, MD
Allopathic & Osteopathic Physicians|Family Medicine · KALAMAZOO, MI · NPI 1770543803
Verified facts
What the public records show
CMS Open Payments records show Keyur Patel, MD received $133.06 in general payments during 2025 across 5 reported records.
Kestra Medical Technology Services, Inc. accounted for 83.9% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 2 associated products.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| Kestra Medical Technology Services, Inc. | Unresolved — no canonical attribution shown | $111.66 | 83.9% | 4 | 2025 |
| CSL Behring | Unresolved — no canonical attribution shown | $21.40 | 16.1% | 1 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Food and Beverage | $133.06 | 5 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| Assure WCD Normalized: assure wcd |
Device | Kestra Medical Technology Services, Inc. | $111.66 | 4 | 2025 |
Source payment records
|
|||||
| Hizentra Normalized: hizentra |
Biological | CSL Behring | $21.40 | 1 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
Public prescribing for products named in payments
No exact normalized or approved-alias overlap was found in the loaded Part D year. This does not mean the doctor never prescribed the product.
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
No publishable same-company prescribing overlap was found in the loaded Part D year. This does not mean the doctor never prescribed a drug reported elsewhere by a paying company.
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Atorvastatin Calcium | Atorvastatin Calcium | 891 | 266 |
| Lisinopril | Lisinopril | 492 | 133 |
| Amlodipine Besylate | Amlodipine Besylate | 452 | 144 |
| Omeprazole | Omeprazole | 334 | 101 |
| Metformin Hcl | Metformin Hcl | 281 | 76 |
| Levothyroxine Sodium | Levothyroxine Sodium | 265 | 74 |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 260 | 98 |
| Gabapentin | Gabapentin | 248 | 56 |
| Metoprolol Succinate | Metoprolol Succinate | 207 | 71 |
| Duloxetine Hcl | Duloxetine Hcl | 205 | 56 |
| Losartan Potassium | Losartan Potassium | 205 | 71 |
| Hydrocodone-Acetaminophen | Hydrocodone/Acetaminophen | 178 | 51 |
| Meloxicam | Meloxicam | 170 | 53 |
| Trazodone Hcl | Trazodone Hcl | 161 | 36 |
| Pantoprazole Sodium | Pantoprazole Sodium | 151 | 45 |
| Furosemide | Furosemide | 138 | 47 |
| Famotidine | Famotidine | 128 | 37 |
| Ozempic | Semaglutide | 127 | 30 |
| Tamsulosin Hcl | Tamsulosin Hcl | 117 | 33 |
| Lisinopril-Hydrochlorothiazide | Lisinopril/Hydrochlorothiazide | 111 | 41 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 107 | 49 |
| Hydrochlorothiazide | Hydrochlorothiazide | 104 | 41 |
| Trelegy Ellipta | Fluticasone/Umeclidin/Vilanter | 103 | 33 |
| Metoprolol Tartrate | Metoprolol Tartrate | 100 | 37 |
| Eliquis | Apixaban | 99 | 25 |
| Januvia | Sitagliptin Phosphate | 97 | 18 |
| Simvastatin | Simvastatin | 97 | 25 |
| Fluticasone Propionate | Fluticasone Propionate | 95 | 37 |
| Escitalopram Oxalate | Escitalopram Oxalate | 92 | 25 |
| Montelukast Sodium | Montelukast Sodium | 88 | 20 |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 87 | 28 |
| Potassium Chloride | Potassium Chloride | 87 | 26 |
| Pregabalin | Pregabalin | 87 | 26 |
| Clopidogrel | Clopidogrel Bisulfate | 84 | 27 |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 84 | 40 |
| Alendronate Sodium | Alendronate Sodium | 80 | 25 |
| Amitriptyline Hcl | Amitriptyline Hcl | 77 | 24 |
| Tizanidine Hcl | Tizanidine Hcl | 77 | 23 |
| Carvedilol | Carvedilol | 74 | 27 |
| Diclofenac Sodium | Diclofenac Sodium | 74 | 33 |
| Ibuprofen | Ibuprofen | 72 | 26 |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 71 | 21 |
| Donepezil Hcl | Donepezil Hcl | 68 | suppressed |
| Hydralazine Hcl | Hydralazine Hcl | 68 | 18 |
| Trulicity | Dulaglutide | 64 | 17 |
| Buspirone Hcl | Buspirone Hcl | 62 | 20 |
| Celecoxib | Celecoxib | 61 | 19 |
| Bupropion Xl | Bupropion Hcl | 58 | 17 |
| Glipizide Er | Glipizide | 58 | 18 |
| Fluoxetine Hcl | Fluoxetine Hcl | 57 | 20 |
| Alprazolam | Alprazolam | 53 | 19 |
| Citalopram Hbr | Citalopram Hydrobromide | 53 | 15 |
| Jardiance | Empagliflozin | 53 | 17 |
| Sertraline Hcl | Sertraline Hcl | 53 | 23 |
| Ezetimibe | Ezetimibe | 49 | 17 |
| Farxiga | Dapagliflozin Propanediol | 48 | 18 |
| Clonidine Hcl | Clonidine Hcl | 47 | 14 |
| Ropinirole Hcl | Ropinirole Hcl | 46 | 12 |
| Allopurinol | Allopurinol | 44 | 15 |
| Ventolin Hfa | Albuterol Sulfate | 44 | 15 |
| Dicyclomine Hcl | Dicyclomine Hcl | 43 | suppressed |
| Quetiapine Fumarate | Quetiapine Fumarate | 43 | 12 |
| Spironolactone | Spironolactone | 43 | 15 |
| Propranolol Hcl | Propranolol Hcl | 42 | suppressed |
| Novolog Flexpen | Insulin Aspart | 41 | 15 |
| Prednisone | Prednisone | 41 | 24 |
| Tramadol Hcl | Tramadol Hcl | 41 | 18 |
| Metformin Hcl Er | Metformin Hcl | 40 | suppressed |
| Baclofen | Baclofen | 39 | suppressed |
| Chlorthalidone | Chlorthalidone | 38 | 11 |
| Hydroxyzine Hcl | Hydroxyzine Hcl | 35 | 17 |
| Torsemide | Torsemide | 35 | suppressed |
| Incruse Ellipta | Umeclidinium Bromide | 34 | suppressed |
| Losartan-Hydrochlorothiazide | Losartan/Hydrochlorothiazide | 33 | 14 |
| Naproxen | Naproxen | 33 | suppressed |
| Levocetirizine Dihydrochloride | Levocetirizine Dihydrochloride | 32 | 11 |
| Mirtazapine | Mirtazapine | 31 | suppressed |
| Pravastatin Sodium | Pravastatin Sodium | 31 | 13 |
| Azithromycin | Azithromycin | 30 | 26 |
| Clonazepam | Clonazepam | 30 | 11 |
| Finasteride | Finasteride | 30 | suppressed |
| Fluticasone-Salmeterol | Fluticasone Propion/Salmeterol | 30 | 11 |
| Nitroglycerin | Nitroglycerin | 30 | 25 |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 29 | 24 |
| Xarelto | Rivaroxaban | 29 | suppressed |
| Amoxicillin | Amoxicillin | 28 | 26 |
| Azelastine Hcl | Azelastine Hcl | 28 | 11 |
| Atenolol | Atenolol | 26 | suppressed |
| Oxybutynin Chloride Er | Oxybutynin Chloride | 26 | suppressed |
| Symbicort | Budesonide/Formoterol Fumarate | 26 | suppressed |
| Fluconazole | Fluconazole | 25 | 20 |
| Pramipexole Dihydrochloride | Pramipexole Di-Hcl | 25 | suppressed |
| Amiodarone Hcl | Amiodarone Hcl | 24 | suppressed |
| Carbamazepine | Carbamazepine | 24 | suppressed |
| Pioglitazone Hcl | Pioglitazone Hcl | 24 | suppressed |
| Tresiba Flextouch U-100 | Insulin Degludec | 24 | suppressed |
| Bumetanide | Bumetanide | 23 | suppressed |
| Linzess | Linaclotide | 23 | suppressed |
| Topiramate | Topiramate | 23 | suppressed |
| Venlafaxine Hcl Er | Venlafaxine Hcl | 22 | suppressed |
| Warfarin Sodium | Warfarin Sodium | 22 | suppressed |
| Methylprednisolone | Methylprednisolone | 21 | 17 |
| Diltiazem 24hr Er (Cd) | Diltiazem Hcl | 20 | suppressed |
| Nano 2nd Gen Pen Needle | Pen Needle, Diabetic | 20 | suppressed |
| Spiriva Handihaler | Tiotropium Bromide | 20 | suppressed |
| Esomeprazole Magnesium | Esomeprazole Magnesium | 19 | suppressed |
| Ondansetron Odt | Ondansetron | 19 | 12 |
| Amlodipine Besylate-Benazepril | Amlodipine Besylate/Benazepril | 18 | suppressed |
| Glipizide | Glipizide | 18 | suppressed |
| Lorazepam | Lorazepam | 18 | suppressed |
| Memantine Hcl | Memantine Hcl | 18 | suppressed |
| Morphine Sulfate | Morphine Sulfate | 18 | suppressed |
| Sulfamethoxazole-Trimethoprim | Sulfamethoxazole/Trimethoprim | 18 | 16 |
| Nystatin | Nystatin | 17 | 12 |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 16 | 15 |
| Metoclopramide Hcl | Metoclopramide Hcl | 16 | suppressed |
| Quetiapine Fumarate Er | Quetiapine Fumarate | 16 | suppressed |
| Synthroid | Levothyroxine Sodium | 16 | suppressed |
| Ultra-Fine Short Pen Needle | Pen Needle, Diabetic | 16 | suppressed |
| Basaglar Kwikpen U-100 | Insulin Glargine,hum.Rec.Anlog | 15 | suppressed |
| Breztri Aerosphere | Budesonide/Glycopyr/Formoterol | 15 | suppressed |
| Fenofibrate | Fenofibrate,micronized | 15 | suppressed |
| Paroxetine Hcl | Paroxetine Hcl | 15 | suppressed |
| Sumatriptan Succinate | Sumatriptan Succinate | 15 | suppressed |
| Megestrol Acetate | Megestrol Acetate | 14 | suppressed |
| Morphine Sulfate Er | Morphine Sulfate | 14 | suppressed |
| Ondansetron Hcl | Ondansetron Hcl | 14 | suppressed |
| Oxybutynin Chloride | Oxybutynin Chloride | 14 | suppressed |
| Digoxin | Digoxin | 13 | suppressed |
| Divalproex Sodium | Divalproex Sodium | 13 | suppressed |
| Fiasp Flextouch | Insulin Aspart (Niacinamide) | 13 | suppressed |
| Isosorbide Dinitrate | Isosorbide Dinitrate | 13 | suppressed |
| Nifedipine Er | Nifedipine | 13 | suppressed |
| Sulfasalazine Dr | Sulfasalazine | 13 | suppressed |
| Benztropine Mesylate | Benztropine Mesylate | 12 | suppressed |
| Bupropion Hcl Sr | Bupropion Hcl | 12 | suppressed |
| Carbamazepine Er | Carbamazepine | 12 | suppressed |
| Cephalexin | Cephalexin | 12 | 11 |
| Ciprofloxacin Hcl | Ciprofloxacin Hcl | 12 | suppressed |
| Dextroamphetamine-Amphetamine | Dextroamphetamine/Amphetamine | 12 | suppressed |
| Diltiazem Hcl | Diltiazem Hcl | 12 | suppressed |
| Meclizine Hcl | Meclizine Hcl | 12 | suppressed |
| Memantine Hcl Er | Memantine Hcl | 12 | suppressed |
| Myrbetriq | Mirabegron | 12 | suppressed |
| Oxycodone-Acetaminophen | Oxycodone Hcl/Acetaminophen | 12 | suppressed |
| Benazepril Hcl | Benazepril Hcl | 11 | suppressed |
| Combivent Respimat | Ipratropium/Albuterol Sulfate | 11 | suppressed |
| Entresto | Sacubitril/Valsartan | 11 | suppressed |
| Nateglinide | Nateglinide | 11 | suppressed |
| Spiriva Respimat | Tiotropium Bromide | 11 | suppressed |
| Triamterene-Hydrochlorothiazid | Triamterene/Hydrochlorothiazid | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $133.06 · 5 records | Kestra Medical Technology Services, Inc. | Assure WCD, Hizentra | — | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error